It’s a yes from the FDA: Njoy granted PMTA for nicotine salts pod system

A modern pod system using nicotine salts from a non–Big Tobacco company has been authorised by the US Food and Drug Administration (FDA) through the premarket tobacco product application (PMTA) pathway.

The landmark decision for Njoy’s Ace closed e-cigarette device and three accompanying tobacco-flavoured e-liquid pods represents two firsts: the first modern system using nicotine salts and the first time a company from outside the Big Tobacco sphere has been granted a PMTA.

...

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information

MORE INFO

Visit store

Check out our reports
available for purchase

View reports

Request a free sample of this report:

“ It’s a yes from the FDA: Njoy granted PMTA for nicotine salts pod system ”

    This file is not available, please fill the form to request your sample page:






    Buy report request information:

    “ It’s a yes from the FDA: Njoy granted PMTA for nicotine salts pod system ”






      A modern pod system using nicotine salts from a non–Big Tobacco company has been authorised by the US Food and Drug Administration (FDA) through the premarket tobacco product application (PMTA) pathway.

      The landmark decision for Njoy’s Ace closed e-cigarette device and three accompanying tobacco-flavoured e-liquid pods represents two firsts: the first modern system using nicotine salts and the first time a company from outside the Big Tobacco sphere has been granted a PMTA.

      ...

      Benefits of subscription plans:

      • Stay informed of any legal and market change in the sector that impacts your organization
      • Maximise resources by getting market and legal data analysis daily in one place
      • Make smart decisions by understanding how the regulatory and market landscape evolves
      • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

      Need help?

      Contact a sales representative right now and don’t wait

      Erik Galavis
      +34 654 320 547
      Email Erik